Inquiry
Form loading...
Premium-grade active ingredients for pharmaceutical, nutraceutical, and cosmetic applications
Retinoic acid (RA), a biologically active metabolite of Vitamin A (retinol), is one of the most studied molecules in modern biomedical science. Its profound role in regulating inflammation, immune response, and cellular differentiation has made it a cornerstone ingredient across pharmaceuticals, nutraceuticals, and advanced cosmetics.
Retinoic acid exerts its anti-inflammatory effects primarily by binding to nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs). These receptor complexes act as transcription factors, directly modulating the expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. By downregulating NF-κB signaling pathways — one of the master regulators of the inflammatory cascade — retinoic acid provides a targeted, multi-pathway approach to inflammation suppression unmatched by many conventional compounds.
Beyond direct cytokine modulation, retinoic acid plays a critical role in the differentiation of regulatory T cells (Tregs) and the suppression of Th17 cells — a balance central to autoimmune disease management. It also reinforces epithelial barrier integrity in the skin, gut, and respiratory tract, reducing the entry points for inflammatory triggers. This dual action — immunomodulatory and barrier-protective — positions retinoic acid as an exceptionally versatile anti-inflammatory agent with systemic benefits.
Retinoic acid exists in multiple isomeric forms: all-trans retinoic acid (ATRA), 13-cis retinoic acid (isotretinoin), and 9-cis retinoic acid, each with distinct receptor affinities and bioavailability profiles. ATRA is predominantly used in pharmaceutical applications due to its potent receptor binding and well-characterized pharmacokinetics. Advanced encapsulation technologies — including liposomal delivery and nanoparticle formulations — are now being deployed to enhance bioavailability and enable targeted delivery to inflamed tissues, dramatically improving therapeutic outcomes.
Retinoic acid demonstrates remarkable synergistic effects when combined with other vitamins and bioactive compounds. Vitamin D3 and retinoic acid together amplify Treg induction, making them a powerful combination for managing chronic inflammatory conditions. Vitamin C enhances retinol-to-retinoic acid conversion efficiency, while Vitamin E provides complementary antioxidant protection that reduces oxidative stress-driven inflammation. These synergies are increasingly leveraged in next-generation nutraceutical formulations targeting systemic inflammatory disorders.
Clinical and preclinical research consistently demonstrates that retinoic acid simultaneously suppresses acute inflammatory pathways while promoting long-term immune tolerance. This dual mechanism makes it uniquely valuable for treating both acute inflammatory flares and chronic inflammatory conditions — from psoriasis and acne to inflammatory bowel disease and metabolic inflammation associated with obesity and type 2 diabetes.
The global retinoic acid and retinoid market is experiencing unprecedented growth, driven by expanding clinical applications, rising prevalence of inflammatory diseases, and surging consumer demand for science-backed skincare and nutraceutical solutions.
The pharmaceutical application of retinoic acid for anti-inflammatory treatments — including dermatology (acne, psoriasis), oncology (APL treatment), and emerging autoimmune therapies — is the largest and fastest-growing market segment. Regulatory approvals for new retinoid-based drug formulations are accelerating globally, particularly in North America, Europe, and Asia-Pacific markets, creating robust B2B demand for pharmaceutical-grade retinoic acid raw materials meeting USP/EP standards.
Consumer awareness of diet-inflammation connections is fueling explosive growth in Vitamin A-based nutraceuticals. Retinoic acid precursors — including retinyl palmitate, retinyl acetate, and beta-carotene — are increasingly incorporated into anti-inflammatory supplement stacks targeting gut health, metabolic syndrome, and immune resilience. The functional food sector is projected to account for over 28% of total Vitamin A derivative consumption by 2028, creating significant opportunities for high-purity raw material suppliers.
The cosmetic retinoid market is undergoing a technological revolution. Beyond traditional retinol formulations, next-generation retinaldehyde and hydroxypinacolone retinoate (HPR) compounds are being developed as gentler, more stable alternatives. Anti-inflammatory positioning is now central to premium skincare marketing, with brands emphasizing redness reduction, barrier repair, and microbiome modulation alongside traditional anti-aging claims. This trend is driving demand for diverse retinoid derivatives at multiple purity grades.
From clinical medicine to advanced skincare and industrial biotechnology, retinoic acid's anti-inflammatory properties are being harnessed across an increasingly diverse range of high-value applications.
Topical and oral retinoic acid formulations remain gold-standard treatments for inflammatory skin conditions including acne vulgaris, rosacea, psoriasis, and atopic dermatitis. ATRA's ability to normalize keratinocyte differentiation while suppressing inflammatory cytokine production makes it uniquely effective. New microencapsulated delivery systems are reducing irritation side effects, significantly expanding the patient population that can benefit from retinoid-based anti-inflammatory dermatology.
Emerging research highlights retinoic acid's role in managing airway inflammation associated with asthma, COPD, and post-viral respiratory syndromes. By promoting regulatory T-cell differentiation and suppressing Th2-mediated eosinophilic inflammation, retinoic acid offers a novel immunomodulatory approach to respiratory disease. Inhalable retinoid formulations are currently in advanced preclinical development, representing a significant future commercial opportunity.
Neuroinflammation is a central feature of neurodegenerative diseases including Alzheimer's, Parkinson's, and multiple sclerosis. Retinoic acid's ability to cross the blood-brain barrier and modulate microglial activation — the primary driver of neuroinflammation — has positioned it as a compelling candidate for neuroprotective therapies. Several clinical trials are investigating retinoid-based interventions for cognitive decline and neuroinflammatory conditions, representing a multi-billion-dollar emerging market.
Retinoic acid demonstrates significant anti-inflammatory activity in joint tissues, modulating the synovial inflammatory response in rheumatoid arthritis and osteoarthritis. By regulating matrix metalloproteinase (MMP) expression and reducing IL-17-driven cartilage degradation, retinoids offer both symptom management and potential disease-modifying effects. Intra-articular retinoid delivery systems are being explored as targeted anti-inflammatory interventions with minimal systemic side effects.
Chronic low-grade inflammation is a primary driver of atherosclerosis and cardiovascular disease. Retinoic acid's capacity to suppress vascular smooth muscle cell inflammatory activation, reduce macrophage foam cell formation, and modulate endothelial NF-κB signaling has generated significant interest in cardioprotective retinoid applications. Nutraceutical formulations combining retinoic acid precursors with omega-3 fatty acids are emerging as evidence-based cardiovascular anti-inflammatory supplements.
The cosmeceutical sector is leveraging retinoic acid's anti-inflammatory properties to address sensitive, reactive, and post-procedure skin. Formulations combining retinoids with ceramides, niacinamide, and peptides create comprehensive anti-inflammatory skincare systems that address redness, sensitivity, and barrier dysfunction simultaneously. Professional-grade retinoid peels and clinical treatment protocols incorporating retinoic acid are becoming standard in medical aesthetics practices worldwide.
Your trusted partner for premium retinoic acid and anti-inflammatory vitamin raw materials
Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. is located in Xi'an, Shaanxi Province, China, and specializes in supplying peptides, food additives, nutritional supplements, traditional Chinese medicine (TCM) extracts, plant extracts, and natural active ingredients. As a dedicated supplier of retinoic acid vitamins and anti-inflammatory bioactive compounds, we serve pharmaceutical, nutraceutical, and cosmetic industry clients worldwide with GMP-certified, rigorously tested raw materials that meet international quality standards.
Qiyuan Kangjian Biotech Co., Ltd.
Our team members are familiar with the trade policies and compliance requirements of various countries, always prioritizing customer needs, strictly controlling quality, and responding efficiently. From order negotiation to after-sales follow-up, dedicated personnel handle the entire process, using professionalism and integrity to build bridges for cross-border cooperation and help partners explore global business opportunities. Our scientific team maintains deep expertise in retinoic acid chemistry, anti-inflammatory mechanisms, and regulatory compliance across major markets including the US, EU, and Asia-Pacific regions.
Contact UsState-of-the-art production infrastructure ensuring the highest quality retinoic acid and anti-inflammatory vitamin raw materials
The company has two major production bases in Weinan and Xianyang. Weinan Shenhekang Bioengineering Co., Ltd., established in 2022, boasts a 6,000-square-meter GMP-compliant production workshop.
Global reach, local expertise — delivering retinoic acid and anti-inflammation vitamin solutions to 36+ countries worldwide
Adhering to the corporate philosophy of "rooted in our initial vision, empowered by biotechnology; upholding integrity and taking steady action to benefit the people" and the belief that "quality is our lifeline," the company leverages its group operating model and global distribution network to serve clients in the pharmaceutical, health product, and cosmetics industries.
Its products have gained global recognition and are exported to over 36 countries in Asia, the Middle East, Europe, North America, Latin America, and Africa. With independent import and export licenses, the company has established strong partnerships with international express companies and air and sea freight forwarders to provide timely and professional services. The company also offers a comprehensive sales and service system, including OEM customization services and tailored solutions for clients with new product ideas but lacking laboratory equipment and human resources.
Explore our full range of premium anti-inflammatory vitamin raw materials and bioactive compounds
